Plunkett Research Online: Kineta Inc

KINETA INC (KA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients’ lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy......


KINETA INC

Ticker: KA
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 206 378-0400
Fax:
Address: 219 Terry Avenue North
Seattle, WA 98109 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Keith BakerCFO/Treasurer
Thierry GuillaudeuxChief Scientific Officer
See More
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients’ lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy......See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture